Stevanato Group (NYSE:STVN) Hits New 12-Month High – Still a Buy?

Shares of Stevanato Group S.p.A. (NYSE:STVNGet Free Report) reached a new 52-week high during trading on Tuesday . The stock traded as high as €25.75 ($29.26) and last traded at €25.40 ($28.86), with a volume of 28624 shares trading hands. The stock had previously closed at €24.78 ($28.16).

Wall Street Analyst Weigh In

A number of equities analysts have commented on STVN shares. UBS Group dropped their price objective on shares of Stevanato Group from $24.00 to $23.50 and set a “neutral” rating for the company in a research note on Friday, March 7th. William Blair reissued an “outperform” rating on shares of Stevanato Group in a research note on Friday, March 7th. Finally, Stephens upgraded Stevanato Group to a “strong-buy” rating in a research report on Monday, April 21st. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of €25.70 ($29.20).

View Our Latest Research Report on STVN

Stevanato Group Trading Down 1.3%

The company’s 50 day moving average price is €21.67 and its two-hundred day moving average price is €21.30. The firm has a market cap of $7.27 billion, a PE ratio of 51.06, a P/E/G ratio of 7.18 and a beta of 0.51. The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22.

Stevanato Group (NYSE:STVNGet Free Report) last issued its quarterly earnings results on Thursday, March 6th. The company reported €0.20 ($0.23) EPS for the quarter, meeting the consensus estimate of €0.20 ($0.23). The company had revenue of €352.68 million for the quarter, compared to the consensus estimate of €346.26 million. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. As a group, sell-side analysts forecast that Stevanato Group S.p.A. will post 0.5 EPS for the current year.

Stevanato Group Increases Dividend

The firm also recently declared an annual dividend, which will be paid on Thursday, July 17th. Stockholders of record on Thursday, June 5th will be issued a $0.0613 dividend. This represents a dividend yield of 0.3%. This is an increase from Stevanato Group’s previous annual dividend of $0.05. The ex-dividend date is Thursday, June 5th. Stevanato Group’s dividend payout ratio is presently 11.76%.

Hedge Funds Weigh In On Stevanato Group

A number of large investors have recently bought and sold shares of the business. SG Americas Securities LLC lifted its position in shares of Stevanato Group by 18.2% during the fourth quarter. SG Americas Securities LLC now owns 15,546 shares of the company’s stock worth $339,000 after purchasing an additional 2,389 shares during the last quarter. Jennison Associates LLC purchased a new position in Stevanato Group in the 4th quarter worth about $20,239,000. Conestoga Capital Advisors LLC lifted its holdings in Stevanato Group by 5.3% during the 4th quarter. Conestoga Capital Advisors LLC now owns 8,082,996 shares of the company’s stock valued at $176,128,000 after buying an additional 407,086 shares in the last quarter. Truist Financial Corp boosted its position in Stevanato Group by 4.2% in the 4th quarter. Truist Financial Corp now owns 26,900 shares of the company’s stock valued at $586,000 after buying an additional 1,073 shares during the period. Finally, Peregrine Capital Management LLC grew its stake in Stevanato Group by 1.9% in the 4th quarter. Peregrine Capital Management LLC now owns 366,078 shares of the company’s stock worth $7,977,000 after acquiring an additional 6,661 shares in the last quarter.

About Stevanato Group

(Get Free Report)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

Featured Articles

Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.